Form 4: Amgen SVP Rachna Khosla Reports Stock Disposals
SEC Form 4 Filing
Rachna Khosla, SVP of Business Development at Amgen, reported disposing of shares to cover tax obligations related to vested restricted stock units.
Summary
- On May 2, 2025, Rachna Khosla, SVP of Business Development at Amgen Inc., disposed of 110 shares of common stock at a price of $283.78.
- Additionally, she disposed of 104 shares of common stock at the same price.
- These transactions were reported on a Form 4 filing with the SEC.
- Following these transactions, Khosla directly owns 9,052 shares of Amgen common stock, which includes 112 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a routine disclosure of stock transactions by a company executive.
Industry Context
Form 4 filings are standard practice for corporate insiders to report transactions in their company's stock, providing transparency to investors.
Key Dates
| Date | Description |
|---|---|
| 05/02/2025 | Date of stock disposal transactions |
| 05/05/2025 | Date of signature on the Form 4 filing |
Keywords
Amgen, Rachna Khosla, Form 4, SEC, Stock Disposal, Dividend Equivalents, AMGN, SVP Business Development
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.